Share chart AnaptysBio, Inc.
Extended chart
Simple chart
About AnaptysBio, Inc.
AnaptysBio, Inc., биотехнологическая компания на клинической стадии, занимается разработкой терапевтических продуктов-кандидатов для лечения воспалений и иммуноонкологических показаний. Продукция компании включает этокимаб, анти-интерлейкин (IL) -33 программу для лечения атопического дерматита, эозинофильной астмы и хронического риносинусита с полипами носа; ANB019, рецептор против IL-36 для генерализованного пустулезного псориаза и ладонно-подошвенного пустулезного псориаза; и противовоспалительные модуляторы контрольных точек при воспалительных заболеваниях. more detailsIPO date | 2017-01-26 |
---|---|
ISIN | US0327241065 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.anaptysbio.com |
Цена ао | 18.44 |
Change price per day: | +0.4367% (20.61) |
---|---|
Change price per week: | +0.7299% (20.55) |
Change price per month: | +13.8% (18.19) |
Change price per 3 month: | +22.85% (16.85) |
Change price per half year: | -32.11% (30.49) |
Change price per year: | -1.43% (21) |
Change price per 3 year: | -0.9095% (20.89) |
Change price per 5 year: | +22.27% (16.93) |
Change price per year to date: | +56.34% (13.24) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
EcoR1 Capital, LLC | 7521024 | 28.1 |
Deep Track Capital, LP | 2036990 | 7.61 |
Tang Capital Management, LLC | 1950609 | 7.29 |
Blackrock Inc. | 1799823 | 6.73 |
Vanguard Group Inc | 1380115 | 5.16 |
Boxer Capital, LLC | 1300000 | 4.86 |
First Light Asset Management, LLC | 1237178 | 4.62 |
Woodline Partners LP | 1194974 | 4.47 |
Great Point Partners LLC | 976981 | 3.65 |
Frazier Life Sciences Management, L.P. | 899700 | 3.36 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Future Tech ETF | 0.11275 | 426.34 | 0.8416 |
Principal Healthcare Innovators ETF | 0.11275 | 618.5 | 0.8416 |
iShares Morningstar Small-Cap Growth ETF | 0.01679 | 596.94 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.01155 | 391.25 | 1.60498 |
iShares Morningstar Small-Cap Value ETF | 0.00735 | 197.28 | 2.50476 |
0.05 | 446.06 | 1.3 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Dennis M. Mulroy | Chief Financial Officer | 448.81k | 1955 (70 years) |
Mr. Eric J. Loumeau | Chief Legal Officer | 685.59k | 1963 (62 years) |
Ms. Beth Mueller | Senior Vice President of Human Resources | N/A | |
Dr. Martin Dahl Ph.D. | Senior Vice President of Research | N/A | |
Mr. Daniel R. Faga | President, CEO & Director | 867.12k | 1980 (45 years) |
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D. | Chief Medical Officer | 656.36k | 1975 (50 years) |
Mr. Benjamin Stone | Chief Business Officer | N/A | |
Mr. Douglas A. Rich M.B.A. | Senior Vice President of CMC | N/A | 1969 (56 years) |
Ms. Monique Da Silva | Senior Vice President of Corporate Affairs | N/A | |
Ms. Priya Raina | Senior Vice President of Clinical Operations |
Address: United States, San Diego, 10421 Pacific Center Court - open in Google maps, open in Yandex maps
Website: http://www.anaptysbio.com
Website: http://www.anaptysbio.com